ArticleCurrent microbiology2025
A Six-Year Investigation of the Emergence and Spread of Human Multidrug-Resistant Salmonella enterica Serovar Enteritidis in Tunisia.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
The study aimed to examine the link between genetic antibiotic resistance and the prevalence of multidrug-resistant Salmonella Enteritidis in Tunisia over six years (2014-2019). About 617 clinical samples (including stools, biopsies, abscesses, and urine) were collected and analyzed using serotyping (slide agglutination method), antimicrobial susceptibility testing (disk diffusion method), and molecular techniques (PCR) for detecting antibiotic resistance genes. A total of 231 Salmonella isolates were obtained, of which serotype Enteritidis accounted for 72.3% (167/231). The majority were obtained from stool samples (70.66%, 118/167). About 59% (68/116) of the isolates were identified as multidrug-resistant, defined as exhibiting resistance to at least one agent in three or more antimicrobial classes. The antimicrobial susceptibility analysis demonstrated resistance rates of 46% for nalidixic acid (106/231), 45.5% for ofloxacin (105/231), 45% for ciprofloxacin (104/231), 43.72% for ampicillin (101/231), 43% for amoxicillin (99/231), and 43.3% for ticarcillin (100/231), highlighting a significant resistance to penicillin and fluoroquinolone classes of antibiotics. Less resistance detected to sulfonamide 16% (37/231), trimethoprim-sulfamethoxazole 8.7% (20/231), and chloramphenicol 1.73% (4/231). The most frequent genetic association was between fluoroquinolone and β-lactam resistance genes (91/116, 78.45%). The most common resistance genes that showed consistent patterns were bla
Indexed as
Identifiers
40715804What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.